Cancer therapies targeted to the epidermal growth factor receptor and its family members

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.16, Iss.2, 2006-02, pp. : 147-164

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predictive Molecular Markers of Response to Epidermal Growth Factor Receptor(EGFR) Family-Targeted Therapies

Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. : 799-812

Bentham Science Publishers

Access to resources Recommend Favorite

Sales of human epidermal growth factor receptor 2 (HER2)-targeting breast cancer therapies are set to grow by 3.3% per annum

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 592, 2009-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Putting the Brakes on Cancer: Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

Pharmaceutical Innovation, Vol. 12, Iss. 1, 2002-12 ,pp. : 12-15

Adis International

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer

By Dancey Janet E.

Drugs, Vol. 67, Iss. 8, 2007-01 ,pp. : 1125-1138

Adis International

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Receptor in the Treatment of Colorectal Cancer: State of the Art

By Diasio Robert B. Fourie Jeanne

Drugs, Vol. 66, Iss. 11, 2006-01 ,pp. : 1441-1463

Adis International

Access to resources Recommend Favorite